JP1697875S - - Google Patents

Info

Publication number
JP1697875S
JP1697875S JPD2021-13384F JP2021013384F JP1697875S JP 1697875 S JP1697875 S JP 1697875S JP 2021013384 F JP2021013384 F JP 2021013384F JP 1697875 S JP1697875 S JP 1697875S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-13384F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of JP1697875S publication Critical patent/JP1697875S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-13384F 2020-12-16 2021-06-16 Active JP1697875S (Direct)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EM83240160003 2020-12-16
EM83240160005 2020-12-16
EM83240160002 2020-12-16
EM83240160001 2020-12-16
EM83240160004 2020-12-16

Publications (1)

Publication Number Publication Date
JP1697875S true JP1697875S (Direct) 2021-10-25

Family

ID=78119100

Family Applications (5)

Application Number Title Priority Date Filing Date
JPD2021-13385F Active JP1698674S (Direct) 2020-12-16 2021-06-16
JPD2021-13384F Active JP1697875S (Direct) 2020-12-16 2021-06-16
JPD2021-13386F Active JP1697876S (Direct) 2020-12-16 2021-06-16
JPD2021-13383F Active JP1697874S (Direct) 2020-12-16 2021-06-16
JPD2021-13382F Active JP1698673S (Direct) 2020-12-16 2021-06-16

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JPD2021-13385F Active JP1698674S (Direct) 2020-12-16 2021-06-16

Family Applications After (3)

Application Number Title Priority Date Filing Date
JPD2021-13386F Active JP1697876S (Direct) 2020-12-16 2021-06-16
JPD2021-13383F Active JP1697874S (Direct) 2020-12-16 2021-06-16
JPD2021-13382F Active JP1698673S (Direct) 2020-12-16 2021-06-16

Country Status (2)

Country Link
US (1) USD1085418S1 (Direct)
JP (5) JP1698674S (Direct)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD658283S1 (en) * 2010-04-19 2012-04-24 Resmed Limited Ventilator
USD708733S1 (en) * 2011-08-05 2014-07-08 Resmed Paris Sas Ventilator
USD699356S1 (en) * 2011-09-06 2014-02-11 General Electric Company Intensive care unit ventilator machine
JP1524772S (Direct) * 2014-09-05 2015-06-01
USD759820S1 (en) * 2014-11-25 2016-06-21 Maquet Critical Care Ab Ventilator core
USD820454S1 (en) * 2015-09-09 2018-06-12 General Electric Company Monitor for an incubator
USD884187S1 (en) * 2017-10-19 2020-05-12 Koninklijke Philips N.V. Respiratory ventilator
USD916287S1 (en) * 2019-01-16 2021-04-13 Versah LLC Drill engine
USD910853S1 (en) * 2019-05-29 2021-02-16 Covidien Lp Cuff pressure regulator
USD1027156S1 (en) * 2020-10-30 2024-05-14 Panotec Co., Ltd. Energy recovery ventilator
USD989291S1 (en) * 2020-12-31 2023-06-13 Corvent Medical, Inc. Ventilator tubing assembly
USD1028243S1 (en) * 2020-12-31 2024-05-21 Corvent Medical Inc. Ventilator user interface and front panel

Also Published As

Publication number Publication date
JP1697876S (Direct) 2021-10-25
JP1697874S (Direct) 2021-10-25
JP1698674S (Direct) 2021-11-01
USD1085418S1 (en) 2025-07-22
JP1698673S (Direct) 2021-11-01

Similar Documents

Publication Publication Date Title
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
JP1697874S (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc
AR134164A1 (es) Modificadores covalentes reversibles de lisina de cdk2 y usos de los mismos
AR134161A1 (es) Compuestos de heteroarilo para el tratamiento del dolor